Login / Signup

Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis.

Carla RognoniOriana CianiSilvia SommarivaIrene BargelliniSherrie BhooriRoberto CioniAntonio FacciorussoRita GolfieriAnnagiulia GramenziVincenzo MazzaferroCristina MosconiFrancesca PonzianiRodolfo SaccoFranco TrevisaniRosanna Tarricone
Published in: BMC cancer (2018)
Radioembolization can be considered a valuable treatment option for patients with intermediate-advanced HCC. These findings enrich the evidence about the economic sustainability of TARE in comparison to standard systemic chemotherapy within the context of a national healthcare service.
Keyphrases
  • healthcare
  • liver metastases
  • locally advanced
  • life cycle
  • combination therapy
  • social media
  • replacement therapy
  • smoking cessation
  • health insurance
  • chemotherapy induced
  • affordable care act
  • data analysis
  • drug induced